These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Metastatic brain lesions may demonstrate photopenia on FDG-PET. Liu Y Clin Nucl Med; 2008 Apr; 33(4):255-7. PubMed ID: 18356662 [TBL] [Abstract][Full Text] [Related]
31. PET scans superior to CT for detection of colon cancer spread. Oncology (Williston Park); 2003 Sep; 17(9):1224, 1293. PubMed ID: 14758809 [No Abstract] [Full Text] [Related]
32. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. Bar-Shalom R; Yefremov N; Guralnik L; Gaitini D; Frenkel A; Kuten A; Altman H; Keidar Z; Israel O J Nucl Med; 2003 Aug; 44(8):1200-9. PubMed ID: 12902408 [TBL] [Abstract][Full Text] [Related]
33. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. Nettelbladt OS; Sundin AE; Valind SO; Gustafsson GR; Lamberg K; Långström B; Björnsson EH J Nucl Med; 1998 Apr; 39(4):640-7. PubMed ID: 9544671 [TBL] [Abstract][Full Text] [Related]
34. [Positron emission tomography for the preoperative staging of esophageal carcinoma]. Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652 [TBL] [Abstract][Full Text] [Related]
35. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889 [TBL] [Abstract][Full Text] [Related]
36. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography for radiation treatment planning. Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216 [TBL] [Abstract][Full Text] [Related]
38. Detection of choriocarcinoma in the lung by FDG positron emission tomography. Zhuang H; Yamamoto AJ; Ghesani N; Alavi A Clin Nucl Med; 2001 Aug; 26(8):723. PubMed ID: 11452190 [No Abstract] [Full Text] [Related]
39. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527 [TBL] [Abstract][Full Text] [Related]
40. Positron emission tomographic-computed tomographic imaging of a uterine sarcoma. Cher S; Lay Ergun E Clin Nucl Med; 2003 May; 28(5):443-4. PubMed ID: 12702956 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]